Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction
Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction
Quick and proper treatment provided by accurate test results
Automated data interpretation and LIS interlocking with Seegene Viewer
Whole process validation from extraction to PCR by whole process control
Automated data interpretation and LIS interlocking with Seegene Viewer
Convenient workflow using Seegene’s automated one platform
Quantitative analysis by cyclic-CMTA
Useful tool for surveillance and infection control
Utilization of the UDG system to prevent carry-over contamination
The result represents co-infection that HPV 16 is high (+++) in the HEX channel, HPV 52 is high(+++) in the Cal Red 610 channel, HPV 35, 61 are high (+++) in the Quasar 670 channel and HPV 40 is intermediate (++) in the Quasar 705 channel .
- Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg
- Prevalence of human papilloma virus in Oman: Genotypes 82 and 68 are dominating
- Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42
- Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women
- HPV screening in the urine of transpeople – A prevalence study
- HPV Molecular Genotyping as a Differential Diagnosis Tool in Cervical Cancer Metastasis